Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer"

被引：0
|
作者：
Matsumoto, Ryuji [1 ]
机构：
[1] Hokkaido Univ, Dept Urol, Grad Sch Med, Sapporo, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2023年 / 30卷 / 03期
关键词：
D O I：
10.1111/iju.15127
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：297 / 297
页数：1
相关论文
共 50 条
  • [41] Performance of MRI-TRUS-guided fusion biopsy to detect progression on active surveillance for low- and intermediate-risk prostate cancer
    Frye, Thomas P.
    Shakir, Nabeel Ahmad
    Abboud, Steven
    George, Arvin Koruthu
    Merino, Maria J.
    Choyke, Peter L.
    Turkbey, Baris
    Wood, Bradford J.
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [42] Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
    Albers, Peter
    Wiegel, Thomas
    Schmidberger, Heinz
    Bussar-Maatz, Roswitha
    Haerter, Martin
    Kristiansen, Glen
    Martus, Peter
    Meisner, Christoph
    Wellek, Stefan
    Grozinger, Klaus
    Renner, Peter
    Burmester, Martin
    Schneider, Fried
    Stoeckle, Michael
    WORLD JOURNAL OF UROLOGY, 2021, 39 (01) : 65 - 72
  • [43] Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance
    Meissner, Valentin H.
    Woll, Mira
    Ankerst, Donna P.
    Schiele, Stefan
    Gschwend, Juergen E.
    Herkommer, Kathleen
    WORLD JOURNAL OF UROLOGY, 2021, 39 (10) : 3763 - 3770
  • [44] Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
    Peter Albers
    Thomas Wiegel
    Heinz Schmidberger
    Roswitha Bussar-Maatz
    Martin Härter
    Glen Kristiansen
    Peter Martus
    Christoph Meisner
    Stefan Wellek
    Klaus Grozinger
    Peter Renner
    Martin Burmester
    Fried Schneider
    Michael Stöckle
    World Journal of Urology, 2021, 39 : 65 - 72
  • [45] Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance
    Sherer, Michael, V
    Leonard, Austin J.
    Nelson, Tyler J.
    Guram, Kripa
    De Moraes, Gustavo Rodrigues
    Javier-Desloges, Juan
    Kane, Christopher
    McKay, Rana R.
    Rose, Brent S.
    Bagrodia, Aditya
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 50 : 61 - 67
  • [46] Active Surveillance for Men with Intermediate Risk Prostate Cancer COMMENT
    Chu, Carissa
    Carroll, Peter
    JOURNAL OF UROLOGY, 2021, 205 (01): : 121 - 121
  • [47] Active Surveillance of Low- Risk- Prostate Cancer
    Weissbach, L.
    UROLOGE, 2015, 54 (06): : 869 - 869
  • [48] Editorial Comment to Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer
    Yashi, Masahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 561 - 562
  • [49] A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients
    Kato, Takuma
    Tohi, Yoichiro
    Honda, Tomoko
    Matsuda, Iori
    Osaki, Yu
    Naito, Hirohito
    Matsuoka, Yuki
    Okazoe, Homare
    Taoka, Rikiya
    Ueda, Nobufumi
    Sugimoto, Mikio
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (08) : 672 - 680
  • [50] Longitudinal regret after treatment for low- and intermediate-risk prostate cancer
    Hurwitz, Lauren M.
    Cullen, Jennifer
    Kim, Daniel J.
    Elsamanoudi, Sally
    Hudak, Jane
    Colston, Maryellen
    Travis, Judith
    Kuo, Huai-Ching
    Rice, Kevin R.
    Porter, Christopher R.
    Rosner, Inger L.
    CANCER, 2017, 123 (21) : 4252 - 4258
12345